Thus, pharmacological inhibition or degradation of DDX5 would also block the abnormal reprogramming of glucose (Warburg effect), lipid and nucleotide metabolisms in cancer to induce apoptosis and cancer cell killing. The gene discussed is DDX5; the disease is cancer.